In such difficult times, the EIP decided to run our next Open Scientific Symposium 2021 as a virtual meeting.
Our organizing committee succeeded in creating an interesting agenda again. We will focus on latest hot topics in the area of immunogenicity such as novel strategies to predict antigenicity, breakthrough immunogenicity assay technologies, clinical relevance of immune responses to biopharmaceuticals and regulatory expectations with respect to the “Integrated Summary of Immunogenicity”. Our main conference will be complemented by an interactive workshop offering hand-on training for cut-point statistics. We are honored that we could attract high class speakers from leading biopharmaceutical companies as well as from regulatory agencies.
Although virtual, we will do our best to make the meeting as interactive as possible to allow participants to address their questions directly to experts in the field.
Daniel Kramer, EIP Chairma